Significance
This work demonstrates the ability of neoadjuvant intratumoral immunotherapy to target local and distant metastatic disease and consequently improve survival.
Trial registration
ClinicalTrials.gov NCT03410901 NCT03831295 NCT01347034 NCT00499083 NCT00365872 NCT04025879.